Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin-Reference-Cited by-同舟云学术

Inhibition of IκB Kinase-Nuclear Factor-κB Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin

Published:2008-06-24 Issue:3 Volume:74 Page:654-661
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Kasinski Andrea L.,Du Yuhong,Thomas Shala L.,Zhao Jing,Sun Shi-Yong,Khuri Fadlo R.,Wang Cun-Yu,Shoji Mamoru,Sun Aiming,Snyder James P.,Liotta Dennis,Fu Haian

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference33 articles.

1. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism

2. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents

3. Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of IκBα Kinase and Akt Activation

4. Bioavailability of Curcumin: Problems and Promises

5. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcuminoid PBPD induces cuproptosis and endoplasmic reticulum stress in cervical cancer via the Notch1/RBP‐J/NRF2/FDX1 pathway;Molecular Carcinogenesis;2024-05-27

2. Anticarcinogenic Potency of EF24: An Overview of Its Pharmacokinetics, Efficacy, Mechanism of Action, and Nanoformulation for Drug Delivery;Cancers;2023-11-20

3. Master Molecules of Spices;Handbook of Spices in India: 75 Years of Research and Development;2023-10-27

4. Discovery of Novel Mono-Carbonyl Curcumin Derivatives as Potential Anti-Hepatoma Agents;Molecules;2023-09-25

5. Mechanism insights of curcumin and its analogues in cancer: An update;Phytotherapy Research;2023-08-30